DE3854575D1 - Reassortantes Rotavirusvakzin. - Google Patents

Reassortantes Rotavirusvakzin.

Info

Publication number
DE3854575D1
DE3854575D1 DE3854575T DE3854575T DE3854575D1 DE 3854575 D1 DE3854575 D1 DE 3854575D1 DE 3854575 T DE3854575 T DE 3854575T DE 3854575 T DE3854575 T DE 3854575T DE 3854575 D1 DE3854575 D1 DE 3854575D1
Authority
DE
Germany
Prior art keywords
rotavirus vaccine
rotavirus
reassortant rotavirus
reassortants
gene encoding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3854575T
Other languages
English (en)
Other versions
DE3854575T2 (de
DE122006000071I1 (de
Inventor
Stanley A Plotkin
H Fred Clark
Paul Offit
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Childrens Hospital of Philadelphia CHOP
Wistar Institute of Anatomy and Biology
Original Assignee
Childrens Hospital of Philadelphia CHOP
Wistar Institute of Anatomy and Biology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22425038&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3854575(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Childrens Hospital of Philadelphia CHOP, Wistar Institute of Anatomy and Biology filed Critical Childrens Hospital of Philadelphia CHOP
Application granted granted Critical
Publication of DE3854575D1 publication Critical patent/DE3854575D1/de
Publication of DE3854575T2 publication Critical patent/DE3854575T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
DE3854575T 1987-11-30 1988-11-30 Reassortantes Rotavirusvakzin. Expired - Lifetime DE3854575T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12647787A 1987-11-30 1987-11-30

Publications (2)

Publication Number Publication Date
DE3854575D1 true DE3854575D1 (de) 1995-11-16
DE3854575T2 DE3854575T2 (de) 1996-05-15

Family

ID=22425038

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19883854575 Pending DE122006000071I1 (de) 1987-11-30 1988-11-30 Reassortantes Rotavirusvakzin
DE3854575T Expired - Lifetime DE3854575T2 (de) 1987-11-30 1988-11-30 Reassortantes Rotavirusvakzin.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE19883854575 Pending DE122006000071I1 (de) 1987-11-30 1988-11-30 Reassortantes Rotavirusvakzin

Country Status (12)

Country Link
EP (1) EP0323708B1 (de)
JP (1) JP2818760B2 (de)
AT (1) ATE128873T1 (de)
AU (1) AU618973B2 (de)
CA (1) CA1303525C (de)
DE (2) DE122006000071I1 (de)
ES (1) ES2079358T3 (de)
GR (1) GR3018262T3 (de)
IL (1) IL88534A (de)
LU (1) LU91297I2 (de)
NL (1) NL300252I2 (de)
ZA (1) ZA888931B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU618963B2 (en) * 1987-08-07 1992-01-16 Institut Pasteur Vaccines whose characteristic epitope is incorporated into a protein of picornavirus, in particular, poliovirus
US5626851A (en) * 1987-11-30 1997-05-06 The Wistar Institute Of Anatomy And Biology Rotavirus reassortant vaccine
WO1992001784A1 (en) * 1990-07-26 1992-02-06 The Wistar Institute Of Anatomy & Biology Rotavirus reassortant vaccine
US5610049A (en) * 1991-05-01 1997-03-11 The Wistar Institute Of Anatomy And Biology Human rotavirus HCR3A and method of growing said rotavirus
US5900238A (en) * 1995-07-27 1999-05-04 Immunex Corporation Vaccine delivery system
ID20581A (id) * 1996-10-18 1999-01-21 Res Fnd For Micbial Diseases O Antigen rotavirus, vaksin dan agen diagnostik untuk infeksi rotavirus, serta metode untuk menghasilkan antigen
CN110903403B (zh) * 2019-12-16 2021-07-13 中国农业大学 一种牛轮状病毒嵌合抗原以及检测牛轮状病毒抗体的胶体金免疫层析试纸卡
KR102374547B1 (ko) * 2021-05-31 2022-03-14 에스케이바이오사이언스(주) 재배열 로타바이러스의 제조 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4571385A (en) * 1983-06-27 1986-02-18 The United States Of America As Represented By The Department Of Health And Human Services Genetic reassortment of rotaviruses for production of vaccines and vaccine precursors
US4636385A (en) * 1985-02-15 1987-01-13 The Wistar Institute Of Anatomy & Biology Vaccine, method for its preparation, and use thereof in vaccinating humans against rotavirus infection

Also Published As

Publication number Publication date
ES2079358T3 (es) 1996-01-16
IL88534A (en) 1994-02-27
EP0323708B1 (de) 1995-10-11
IL88534A0 (en) 1993-12-08
GR3018262T3 (en) 1996-02-29
DE3854575T2 (de) 1996-05-15
EP0323708A1 (de) 1989-07-12
AU2630688A (en) 1989-06-01
JP2818760B2 (ja) 1998-10-30
LU91297I2 (fr) 2007-02-20
JPH02138970A (ja) 1990-05-28
AU618973B2 (en) 1992-01-16
CA1303525C (en) 1992-06-16
ATE128873T1 (de) 1995-10-15
ZA888931B (en) 1989-07-26
DE122006000071I1 (de) 2007-04-05
NL300252I1 (nl) 2007-01-01
NL300252I2 (nl) 2007-06-01

Similar Documents

Publication Publication Date Title
NL300252I1 (nl) Rotavirus-reassortanten-vaccin.
FI892131A0 (fi) Analoger till underenheter av bordetellatoxin, vilka haerstammar fraon hybrid-dna.
NO20015073L (no) Vaksiner
EP0192404A3 (de) Impfstoff, Verfahren zur Herstellung desselben und seine Anwendung für die Impfung von Menschen gegen eine Rotavirus-Infektion
ES2089316T3 (es) Agente viral asociado con la enfermedad porcina misteriosa (mystery swine desease).
DK0557427T3 (da) Human rotavira, vacciner og fremgangsmåder
DE69738271D1 (de) Rotavirus-impfstoff
AU3150584A (en) Genetic reassortment of rotaviruses for production of vaccines and vaccine precursors
GR3024173T3 (en) Assembled viral particles and their use in a vaccine to rotaviral disease.
HU9701586D0 (en) Improved inactivated vaccines
DK0493575T3 (da) Vaccine af reassortant rotavirus
Zapikian et al. Alternative approaches to the development of a rotavirus vaccine.
EP0636030A4 (de) Impfstoff gegen das bacterientoxoid aus -i (pasteurellia haemolytica).
Lanata et al. Safety, immunogenicity and efficacy of one or three doses of the rhesus tetravalent rotavirus vaccine in Lima, Peru
EP0293333A3 (en) A synthetic nonapeptide of use as an adjuvant
IT1233419B (it) Peptidi sintetici immunologicamente attivi utili per la preparazione di un vaccino antimalaria
FR2796282B1 (fr) Vaccin inactive contre la calicivirose feline
Lovgren Construction and potential of the iscom as immunogen.
Flewett Rotaviruses: expectations for a vaccine
Vesikari Rotavirus vaccines for prevention of acute gastroenteritis in young infants
Ijaz et al. Potentials of synthetic peptides as rotavirus vaccine and therapy

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
V448 Application of spc

Free format text: PRODUCT NAME: ROTA TEQ; REGISTRATION NO/DATE: EU/1/06/348/001, EU/1/06/348/002; 20060627

Spc suppl protection certif: 12 2006 000 071

Filing date: 20061227